908 Devices (MASS) Share-based Compensation Growth (1y) (2021 - 2026)
908 Devices (MASS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 12.94% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 59.09% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -30.44% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 26.61% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 31.63% |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn | 1.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.44% |
| Dec 31, 2025 | 619.01% |
| Sep 30, 2025 | 3.43% |
| Jun 30, 2025 | 4.80% |
| Mar 31, 2025 | 28.60% |
| Dec 31, 2024 | -121.59% |
| Sep 30, 2024 | -14.94% |
| Jun 30, 2024 | -13.54% |
| Mar 31, 2024 | -15.10% |
| Dec 31, 2023 | 16.72% |
| Sep 30, 2023 | 33.86% |
| Jun 30, 2023 | 36.11% |
| Mar 31, 2023 | 68.04% |
| Dec 31, 2022 | 129.55% |
| Sep 30, 2022 | 149.08% |
| Jun 30, 2022 | 293.76% |
| Mar 31, 2022 | 280.24% |
| Dec 31, 2021 | 184.36% |
| Sep 30, 2021 | 877.11% |
| Jun 30, 2021 | 597.10% |